Nahyeon Kang

556 total citations
17 papers, 419 citations indexed

About

Nahyeon Kang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nahyeon Kang has authored 17 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Nahyeon Kang's work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Nahyeon Kang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Nahyeon Kang collaborates with scholars based in South Korea, United States and Brazil. Nahyeon Kang's co-authors include Seung Joon Kim, Young Kyoon Kim, Bit Na Kim, Chang Dong Yeo, Chan Kwon Park, Jong Y. Park, Hyeon Woo Yim, Mi Sun Park, Sug Hyung Lee and Su Yeon Choi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Nahyeon Kang

16 papers receiving 416 citations

Peers

Nahyeon Kang

ONCOL

PRM

IMMUN

Frances K. Turrell United Kingdom

Nishanth Belugali Nataraj Israel

Laura Pisarsky Switzerland

Yvonne E. Smith Ireland

Maojia Zhao China

Sara R. Martins‐Neves Portugal

Qing-Shan Wang China

Ying-Hui Zhu China

Yanyun Zhao China

Stephany Fiore Italy

Frances K. Turrell United Kingdom

Nahyeon Kang

243 ×0.9

197 ×1.0

170 ×1.0

ONCOL

79 ×1.0

PRM

43 ×0.8

IMMUN

Citations per year, relative to Nahyeon Kang Nahyeon Kang (= 1×) peers Frances K. Turrell

Countries citing papers authored by Nahyeon Kang

Since Specialization

Citations

This map shows the geographic impact of Nahyeon Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahyeon Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahyeon Kang more than expected).

Fields of papers citing papers by Nahyeon Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahyeon Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahyeon Kang. The network helps show where Nahyeon Kang may publish in the future.

Co-authorship network of co-authors of Nahyeon Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Nahyeon Kang. A scholar is included among the top collaborators of Nahyeon Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahyeon Kang. Nahyeon Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kang, Nahyeon, Veedamali S. Subramanian, & Anshu Agrawal. (2025). Influence of Aging and Immune Alterations on Susceptibility to Pneumococcal Pneumonia in the Elderly. Pathogens. 14(1). 41–41.

Hong, Sook Hee, et al.. (2025). Abstract 1374: Targeting lipid-laden macrophage efferocytosis enhances immune response to EGFR-tyrosine kinase inhibitor in EGFR-mutant lung cancer. Cancer Research. 85(8_Supplement_1). 1374–1374. 1 indexed citations

Park, Se Jun, Hyunho Kim, Myung Ah Lee, et al.. (2023). Early Increase in Circulating PD-1+CD8+ T Cells Predicts Favorable Survival in Patients with Advanced Gastric Cancer Receiving Chemotherapy. Cancers. 15(15). 3955–3955. 4 indexed citations

Park, Se Jun, Myung Ah Lee, Jae Myung Park, et al.. (2023). Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy. Scientific Reports. 13(1). 6952–6952. 24 indexed citations

Hong, Sook Hee, et al.. (2022). EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer. Cancers. 15(1). 124–124. 7 indexed citations

Kang, Nahyeon, et al.. (2022). Prognostic significance of exosomal programmed death-ligand 1 in advanced gastric cancer patients treated with first-line chemotherapy.. Journal of Clinical Oncology. 40(4_suppl). 665–665. 1 indexed citations

Kim, Bit Na, Dong Hyuck Ahn, Nahyeon Kang, et al.. (2020). TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer. Scientific Reports. 10(1). 10597–10597. 152 indexed citations

Park, Jong Y., Hung N. Luu, Hyun Y. Park, et al.. (2019). Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma. Translational Cancer Research. 8(S4). S397–S403. 2 indexed citations

Kang, Nahyeon, Su Yeon Choi, Bit Na Kim, et al.. (2019). Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation. BMC Cancer. 19(1). 148–148. 27 indexed citations

10.

Choi, Su Yeon, Hyung Woo Kim, Bit Na Kim, et al.. (2019). Comparison of PANAMutyper and PNAClamp for Detecting KRAS Mutations from Patients With Malignant Pleural Effusion. In Vivo. 33(3). 945–954. 2 indexed citations

11.

Kim, Hyung Woo, Bit Na Kim, Nahyeon Kang, et al.. (2019). Comparison of PNA Clamping-assisted Fluorescence Melting Curve Analysis and PNA Clamping in Detecting EGFR Mutations in Matched Tumor Tissue, Cell Block, Pleural Effusion and Blood of Lung Cancer Patients With Malignant Pleural Effusion. In Vivo. 33(2). 595–603. 4 indexed citations

12.

Hong, Sook Hee, et al.. (2019). Abstract 1192: Increased regulatory T cells induced by glycolytic metabolic change in EGFR mutant NSCLC after EGFR TKI therapy. Cancer Research. 79(13_Supplement). 1192–1192. 1 indexed citations

13.

Kang, Nahyeon, et al.. (2018). P2.03-16 TGF-β Induced EMT and Stemness Characteristics are Associated with Epigenetic Regulation in Lung Cancer. Journal of Thoracic Oncology. 13(10). S722–S722. 1 indexed citations

14.

Yeo, Chang Dong, Nahyeon Kang, Su Yeon Choi, et al.. (2017). The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation. The Korean Journal of Internal Medicine. 32(4). 589–599. 84 indexed citations

15.

Luu, Hung N., Hui‐Yi Lin, Karina D. Sørensen, et al.. (2017). miRNAs associated with prostate cancer risk and progression. BMC Urology. 17(1). 18–18. 91 indexed citations

16.

Yeo, Chang Dong, Gyeong Sin Park, Nahyeon Kang, et al.. (2015). Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance. Annals of Surgical Oncology. 22(S3). 1365–1370. 5 indexed citations

17.

Kang, Nahyeon, Su Yeon Choi, Young Kyoon Kim, et al.. (2015). Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer. Lung Cancer. 89(2). 99–103. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact